Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

January 31, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Jan. 31, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic...

Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification

January 30, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 31, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc.,  have received a Paragraph IV Certification Notice from Mylan Technologies Inc. advising of the filing of an Abbreviated...

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011

January 30, 2011 1:31 pm | by Bio-Medicine.Org | News | Comments

DETROIT, Jan. 30, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for...

Advertisement

Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.

January 28, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

DENVER, Jan. 28, 2011 /- Burg Simpson Eldredge Hersh & Jardine, P.C., one of the nation's leading plaintiff litigation law firms, is delighted to announce that shareholder, Seth. A. Katz, has been appointed by the Hon. David A. Katz to serve as a member of the Plaintiffs' Steering...

Physiotherapy Associates Announces New Clinic in Castle Rock, CO

January 28, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

EXTON, Penn., Jan. 28, 2011 /- Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces a new clinic location in Castle Rock, CO. The clinic offers a comprehensive range of physical therapy services, including: orthopedics; back and neck...

Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association

January 28, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

FAIRFIELD, N.J., Jan. 28, 2011 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) announced that its 2011 "Woman of the Year" is Freda Lewis-Hall, MD, chief medical officer of Pfizer. In her distinguished 30-year career, Dr. Lewis-Hall has held leadership...

VirtualScopics Schedules Fourth Quarter/Full Year 2010 Earnings Announcement

January 28, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Jan. 28, 2011 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, today announced that before the market opens on Thursday, February 24, 2011 it will release its fourth quarter and full year 2010 financial results. The...

TechniScan to Present Live, Online at RetailInvestorConferences.com on February 3rd

January 28, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Jan. 28, 2011 /- TechniScan (OTC Bulletin Board: TSNI ), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, today announced that Dave Robinson, Chief Executive Officer, will present at...

Advertisement

Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results

January 28, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 28, 2011 /- Awarepoint Corporation, a privately held San Diego-based corporation, today announced it ended 2010 with 91 hospital sites contracted consisting of 45,062,013 million square feet of real-time location system (RTLS) network coverage in U.S. hospitals and 135,265...

Endo Pharmaceuticals and Orion Corporation Begin Novel R & D Collaboration

January 27, 2011 10:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 28, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology. The formation of this R&D...

Varian Medical Systems' Security and Inspection Products Group Receives Largest Single Order for IntellX Systems

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, Jan. 27, 2011 /- Varian Medical Systems (NYSE: VAR ) today announced it has received a $21 million order from U.S. Customs and Border Protection (CBP) for multiple IntellX® cargo container screening systems. The order, booked this month, represents the company's largest...

CareCentrix to Present at Hospital Readmissions Conference

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

HARTFORD, Conn., Jan. 27, 2011 /- CareCentrix, Inc ., the nation's leading provider of home health benefits management services, will present tomorrow at the World Congress' 2nd Annual Leadership Summit on Hospital Re-Admissions in Washington, D.C.  Dr. William Kerr, Chief Medical...

Zimmer Reports Fourth Quarter and 2010 Financial Results

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Jan. 27, 2011 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter and year ended December 31, 2010.  The Company reported fourth quarter net sales of $1.13 billion, an increase of 2.5% reported and 3.0% constant currency over...

Advertisement

DSM Joins International Response to Flooding in Australia

January 26, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Jan. 27, 2011 /- Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011.  Thousands of residents were affected.  A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December...

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Elementâ„¢ Everolimus-Eluting Stent

January 26, 2011 3:32 am | by Boston Scientific | News | Comments

PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent

His Highness Sheikh Mohammed bin Zayed Al Nahyan and the Bill & Melinda Gates Foundation Partner to Immunize Children

January 26, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE and ABU DHABI, United Arab Emirates, Jan. 26, 2011 /PRNewswire-USNewswire/ -- His Highness Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, and Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation,...

Global Genes Project Announces 'Wear That You Careâ„¢' Denim Awareness Campaign for Rare Disease Day 2011

January 26, 2011 1:33 am | by Bio-Medicine.Org | News | Comments

DANA POINT, Calif., Jan. 26, 2011 /- Monday, February 28, 2011, is the 4th annual Rare Disease Day — a day when people worldwide will show their support for the millions of people suffering from rare diseases and disorders.  According to statistics from the National Institutes...

Database architecture, interface design key in researcher's aim for future EMR

January 25, 2011 12:35 pm | by Arizona State University | News | Comments

Graduate researcher Kyle Larkin analyzes the hit and misses of the EMR industry in hope to develop a seamless database architecture that benefits all users.read more

Reportlinker Adds Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry

January 25, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Brand Erosion Post-Patent Expiry – An analysis of small molecule brand erosion post-patent expiry...

Reportlinker Adds The Top 10 CMOs in China

January 25, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Top 10 CMOs in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html IntroductionThis report discusses market dynamics, drivers, resistors and...

Reportlinker Adds The Drug Discovery Outsourcing Market

January 25, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Drug Discovery Outsourcing Market http://www.reportlinker.com/p0363588/The-Drug-Discovery-Outsourcing-Market.html Introduction This report investigates current trends...

Reportlinker Adds The Drug Delivery Device Market Outlook to 2015

January 25, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Drug Delivery Device Market Outlook to 2015 http://www.reportlinker.com/p0363596/The-Drug-Delivery-Device-Market-Outlook-to-2015.html Drug delivery device...

Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer

January 25, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

EAST BRUNSWICK, N.J., Jan. 25, 2011 /- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that its board of directors has named John H. Johnson as Chief Executive Officer, effective January 31, 2011.  Mr. Johnson will also serve as a member of Savient's board of directors....

PDL BioPharma Appoints Caroline Krumel as Vice President of Finance and Thanks Karen Wilson for her Contributions

January 25, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

INCLINE VILLAGE, Nev., Jan. 25, 2011 /- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced the appointment of Caroline Krumel, CPA to the position of vice president of finance and chief accounting officer, effective January 31, 2011. Ms. Krumel will replace Karen Wilson, who is...

Angelini Labopharm Confirms Appointment of Mary Anne Heino as President

January 25, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 25, 2011 /- Angelini Labopharm, LLC, today confirmed Mary Anne Heino's appointment as President of the Company.  Formerly Senior Vice President, Sales and Marketing for Labopharm Inc. and President of the company's wholly owned subsidiary, Labopharm USA, Inc.,...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading